Correlation Between Bolt Biotherapeutics and Coya Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Bolt Biotherapeutics and Coya Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bolt Biotherapeutics and Coya Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bolt Biotherapeutics and Coya Therapeutics, Common, you can compare the effects of market volatilities on Bolt Biotherapeutics and Coya Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bolt Biotherapeutics with a short position of Coya Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bolt Biotherapeutics and Coya Therapeutics,.
Diversification Opportunities for Bolt Biotherapeutics and Coya Therapeutics,
0.57 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Bolt and Coya is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Bolt Biotherapeutics and Coya Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coya Therapeutics, Common and Bolt Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bolt Biotherapeutics are associated (or correlated) with Coya Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coya Therapeutics, Common has no effect on the direction of Bolt Biotherapeutics i.e., Bolt Biotherapeutics and Coya Therapeutics, go up and down completely randomly.
Pair Corralation between Bolt Biotherapeutics and Coya Therapeutics,
Given the investment horizon of 90 days Bolt Biotherapeutics is expected to generate 0.96 times more return on investment than Coya Therapeutics,. However, Bolt Biotherapeutics is 1.04 times less risky than Coya Therapeutics,. It trades about -0.16 of its potential returns per unit of risk. Coya Therapeutics, Common is currently generating about -0.29 per unit of risk. If you would invest 64.00 in Bolt Biotherapeutics on September 13, 2024 and sell it today you would lose (7.52) from holding Bolt Biotherapeutics or give up 11.75% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bolt Biotherapeutics vs. Coya Therapeutics, Common
Performance |
| Timeline |
| Bolt Biotherapeutics |
| Coya Therapeutics, Common |
Bolt Biotherapeutics and Coya Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bolt Biotherapeutics and Coya Therapeutics,
The main advantage of trading using opposite Bolt Biotherapeutics and Coya Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bolt Biotherapeutics position performs unexpectedly, Coya Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coya Therapeutics, will offset losses from the drop in Coya Therapeutics,'s long position.| Bolt Biotherapeutics vs. Assembly Biosciences | Bolt Biotherapeutics vs. Instil Bio | Bolt Biotherapeutics vs. CytomX Therapeutics | Bolt Biotherapeutics vs. Achilles Therapeutics PLC |
| Coya Therapeutics, vs. Cue Biopharma | Coya Therapeutics, vs. Lantern Pharma | Coya Therapeutics, vs. Fennec Pharmaceuticals | Coya Therapeutics, vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |